SCHEDULE 13D/A//SEC Filing
LakeShore Biopharma Co., Ltd. SCHEDULE 13D/A
Accession 0001213900-25-105655
CIK 0002078050other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 8:50 AM ET
Size
436.6 KB
Accession
0001213900-25-105655
Documents
- SCHEDULEprimary_doc.xml
- EX-99.10ea026355001ex99-10_lake.htm
JOINT FILING AGREEMENT DATED NOVEMBER 4, 2025 BY AND AMONG THE REPORTING PERSONS
- EX-99.12ea026355001ex99-12_lake.htm
EQUITY COMMITMENT LETTER, DATED NOVEMBER 4, 2025, BY AND BETWEEN THE SPONSOR AND PARENT
- EX-99.13ea026355001ex99-13_lake.htm
ROLLOVER AND SUPPORT AGREEMENT, DATED NOVEMBER 4, 2025, BY AND AMONG THE ROLLOVER SHAREHOLDERS AND PARENT
- EX-99.14ea026355001ex99-14_lake.htm
LIMITED GUARANTEE, DATED NOVEMBER 4, 2025, BY AND BETWEEN THE SPONSOR AND THE ISSUER
- EX-99.15ea026355001ex99-15_lake.htm
INTERIM INVESTORS AGREEMENT, DATED NOVEMBER 4, 2025, BY AND AMONG THE CONSORTIUM MEMBERS, PARENT AND MERGER SUB
Issuer
Crystal Peak Investment Inc.
CIK 0002078050
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0002078050
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 8:50 AM ET
- Size
- 436.6 KB